Product NDC: | 35356-392 |
Proprietary Name: | Mirapex |
Non Proprietary Name: | Pramipexole Dihydrochloride |
Active Ingredient(s): | .125 mg/1 & nbsp; Pramipexole Dihydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 35356-392 |
Labeler Name: | Lake Erie Medical DBA Quality Care Products LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020667 |
Marketing Category: | NDA |
Start Marketing Date: | 20101005 |
Package NDC: | 35356-392-30 |
Package Description: | 30 TABLET in 1 BOTTLE, PLASTIC (35356-392-30) |
NDC Code | 35356-392-30 |
Proprietary Name | Mirapex |
Package Description | 30 TABLET in 1 BOTTLE, PLASTIC (35356-392-30) |
Product NDC | 35356-392 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Pramipexole Dihydrochloride |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20101005 |
Marketing Category Name | NDA |
Labeler Name | Lake Erie Medical DBA Quality Care Products LLC |
Substance Name | PRAMIPEXOLE DIHYDROCHLORIDE |
Strength Number | .125 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Dopamine Agonists [MoA],Nonergot Dopamine Agonist [EPC] |